Identification of anti-HIV and anti-Reverse Transcriptase activity from Tetracera scandens
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
We report here that an ethanol extract of Tetracera scandens, a Vietnamese medicinal plant, has anti-HIV activity and possesses strong inhibitory activity against HIV-1 reverse transcriptase (RTase). Using a MT-4 cell-based assay, we found that the T. scandens extract inhibited effectively HIV virus replication with an IC50 value in the range of 2.0-2.5 μg/ml while the cellular toxicity value (CC50) was more than 40-50 μg/ml concentration, thus yielding a minimum specificity index of 20-fold. Moreover, the anti-HIV efficacy of the T. scandens extract was determined to be due, in part, to its potent inhibitory activity against HIV-1 RTase activity in vitro. The inhibitory activity against the RTase was further confirmed by probing viral cDNA production, an intermediate of viral reverse transcription,in virus-infected cells using quantitative DNA-PCR analysis. Thus, these results suggest that T. scandens can be a useful source for the isolation and development of new anti-HIV-1 inhibitor(s). [BMB reports 2012; 45(3): 165-170]
Abstract
We report here that an ethanol extract of Tetracera scandens, a Vietnamese medicinal plant, has anti-HIV activity and possesses strong inhibitory activity against HIV-1 reverse transcriptase (RTase). Using a MT-4 cell-based assay, we found that the T. scandens extract inhibited effectively HIV virus replication with an IC50 value in the range of 2.0-2.5 μg/ml while the cellular toxicity value (CC50) was more than 40-50 μg/ml concentration, thus yielding a minimum specificity index of 20-fold. Moreover, the anti-HIV efficacy of the T. scandens extract was determined to be due, in part, to its potent inhibitory activity against HIV-1 RTase activity in vitro. The inhibitory activity against the RTase was further confirmed by probing viral cDNA production, an intermediate of viral reverse transcription,in virus-infected cells using quantitative DNA-PCR analysis. Thus, these results suggest that T. scandens can be a useful source for the isolation and development of new anti-HIV-1 inhibitor(s). [BMB reports 2012; 45(3): 165-170]
참고문헌 (21)
- Feng, J. Y., "The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study", Retrovirology, 6, pp.44~ (2009)
- King, R. W., "Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors", Antimicrob. Agents Chemother, 46, pp.1640~1646 (2002)
- Dierynck, I., "Binding kinetics of darunavir to human immunodeficiency virus type 1 protease explain the potent antiviral activity and high genetic barrier", J. Virol., 81, pp.13845~13851 (2007)
- Blanco, J. L., "HIV-1 integrase inhibitor resistance and its clinical implications", J. Infect. Dis., 203, pp.1204~1214 (2011)
- Ji, C., "CD4-anchoring HIV-1 fusion inhibitor with enhanced potency and in vivo stability", J. Biol. Chem., 284, pp.5175~5185 (2009)
- Zhou, N., "In vivo patterns of resistance to the HIV attachment inhibitor BMS-488043. Antimicrob", Agents Chemother, 55, pp.729~737 (2011)
- Adamson, C. S., "In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat)", J. Virol., 80, pp.10957~10971 (2006)
- Adamson, C. S., "Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457)", J. Virol., 83, pp.4884~4894 (2009)
- Latinovic, O., "Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc", Clin. Med. Ther., 1, pp.1497~1510 (2009)
- Hupfeld, J., "Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products", In Vivo, 23, pp.1~6 (2009)
- Yogeeswari, P., "Betulinic acid and its derivatives: a review on their biological properties", Curr. Med. Chem., 12, pp.657~666 (2005)
- Fujioka, T., "Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids", J. Nat. Prod., 57, pp.243~247 (1994)
- Kashman, Y., "The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum", J. Med. Chem., 35, pp.2735~2743 (1992)
- Johnson, S. C., "Advances in HIV", AIDS therapy, 2000, pp.45, 1~40
- Notka, F., "Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo", Antiviral. Res., 64, pp.93~102 (2004)
- Zhu, H., "The tropical rainforest vegetation in Xishuangbanna", Chinese Geographical Science, 2, pp.64~73 (1992)
- 김미리, "Genistein-Derivatives from Tetracera scandens Stimulate Glucose-Uptake in L6 Myotubes", BIOLOGICAL PHARMACEUTICAL BULLETIN, 32(3), pp.504~508, PHARMACEUTICAL SOC JAPAN
- Umar, A., "Anti-hyperglycemic activity of the leaves of Tetracera scandens Linn. Merr. (Dilleniaceae) in alloxan induced diabetic rats", J. Ethnopharmacol., 131, pp.140~145 (2010)
- Nguyen, M. T., "Xanthine oxidase inhibitory activity of Vietnamese medicinal plants", Biol. Pharm. Bull., 27, pp.1414~1421 (2004)
- Ma, J., "DNA polymerase beta inhibitors from Tetracera boiviniana", J. Nat. Prod., 62, pp.1660~1663 (1999)
- Schlaepfer, E., "CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo", J. Virol., 78, pp.12344~12354 (2004)